Penn Prevention Clinical Trials Unit

The HIV/AIDS Clinical Trials Networks was created by the National Institute of Allergy and Infectious Diseases (NIAID) to develop and conduct clinically relevant, scientifically sound, interdisciplinary and cost-efficient HIV/AIDS research in the following areas: (1) Vaccine Research and Development; (2) Translational Research/Drug Development; (3) Optimization of Clinical Management, Including Co-Morbidities; (4) Microbicides; (5) Prevention of Mother-to-Child Transmission (MTCT) of HIV; and (6) Prevention of HIV Infection.

The research studies will be conducted by Clinical Trials Units at sites that reach populations most affected or threatened by the HIV/AIDS epidemic both here in the U.S. and abroad. The Penn Prevention Clinical Trials Unit (PPCTU) was selected in late 2006 as a site to conduct Vaccine clinical trials. The main focus of our work is to identify high risk populations in the Philadelphia area and seek their participation in Network clinical trials. Another goal of our work is to serve as a community resource and educate participants and local communities about HIV/AIDS and related clinical research studies.

For more information or to schedule a speaker, call: (215) 746-7355

 

Connect with us